ABVC BioPharma Inc. (NASDAQ: ABVC)
$0.79
+0.0020 ( +0.25% ) 42.9K
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
Market Data
Open
$0.79
Previous close
$0.79
Volume
42.9K
Market cap
$9.57M
Day range
$0.79 - $0.82
52 week range
$0.67 - $6.87
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 87 | May 17, 2024 |
nt | Quarterly Reports | 1 | May 15, 2024 |
8-k | 8K-related | 17 | May 15, 2024 |
8-k | 8K-related | 17 | May 15, 2024 |
nt | Quarterly Reports | 1 | May 15, 2024 |
8-k | 8K-related | 17 | May 09, 2024 |
8-k | 8K-related | 17 | May 09, 2024 |
pre | Proxies and info statements | 1 | Apr 26, 2024 |
pre | Proxies and info statements | 1 | Apr 26, 2024 |
8-k | 8K-related | 13 | Apr 19, 2024 |